Blanca Gonzalez-Sanchez

Barcelona, CT 08003, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma.

Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma.

Journal: Cancers

Published: January 26, 2026

Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia.

Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia.

Journal: Journal of clinical medicine

Published: January 24, 2026

Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI).

Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI).

Journal: British journal of haematology

Published: January 23, 2026

Combining an immunomodulatory drug with a TPO-RA to treat multirefractory ITP patients: The Spanish ITP Group experience.

Combining an immunomodulatory drug with a TPO-RA to treat multirefractory ITP patients: The Spanish ITP Group experience.

Journal: British journal of haematology

Published: June 18, 2025

Concomitant treatment with systemic and intralesional brentuximab for resistant CD30+ mycosis fungoides lesions.

Concomitant treatment with systemic and intralesional brentuximab for resistant CD30+ mycosis fungoides lesions.

Journal: European journal of dermatology : EJD

Published: May 26, 2025

Genomic characterization of clonal B-cell lymphocytosis of marginal zone origin with MYC rearrangements.

Genomic characterization of clonal B-cell lymphocytosis of marginal zone origin with MYC rearrangements.

Journal: Virchows Archiv : an international journal of pathology

Published: April 30, 2025

Poly (ADP-Ribose) Polymerase 1 and 2 in B-Cell Lymphoma: Pathogenic Roles and Therapeutic Implications.

Poly (ADP-Ribose) Polymerase 1 and 2 in B-Cell Lymphoma: Pathogenic Roles and Therapeutic Implications.

Journal: The American journal of pathology

Published: April 30, 2025

From Clinical Perception to Implicit Bias: Understanding Personality Traits in Lymphoma Patients.

From Clinical Perception to Implicit Bias: Understanding Personality Traits in Lymphoma Patients.

Journal: Cancers

Published: March 31, 2025

Retreatment with Brentuximab Vedotin in Patients with Relapsed/Refractory CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain-The BELIEVE Study.

Retreatment with Brentuximab Vedotin in Patients with Relapsed/Refractory CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain-The BELIEVE Study.

Journal: Cancers

Published: February 19, 2025

Combined immunohistochemical profile CD10/LMO2/MYC is a useful tool to screen MYC rearrangements in aggressive large B-cell lymphomas.

Combined immunohistochemical profile CD10/LMO2/MYC is a useful tool to screen MYC rearrangements in aggressive large B-cell lymphomas.

Journal: Virchows Archiv : an international journal of pathology

Published: August 16, 2024

Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI).

Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI).

Journal: American journal of hematology

Published: August 13, 2024

Interplay of leucocyte-platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients.

Interplay of leucocyte-platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients.

Journal: British journal of haematology

Published: May 16, 2024

Showing 1-12 of 69

Last Updated: 09/26/2026